Speaker illustration

Doctor Teruki Sato

Akita University Graduate School of Medicine, Akita (Japan)

A novel APJ ligand, ELABELA/Apela/Toddler, protects from pressure overload- and Angiotensin II-induced cardiac hypertrophy and fibrosis

Event: ESC Congress 2017

Topic: Basic Science

Session: Remodelling and cardioprotection


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb